UUID: 3953AC4A- A7BB- 4257- BFEB- 1511D2F6R61é|TlAEa
TC GA- Y-L- ABSI- OIA- PR

||||||||||||||||||||||||||||||||||||l|||||||||||||IlllllRlllllllallcll‘2th
||||I||||||||||||l||||||||||||I|| ||||| ||||||||||I||| III ”III"
|||||||||||||||||I||||||||||||II||||||||||||||||||||||||||||||||

PROSTATE AND PELVIC/OBTURATOR LYMPH NODEs- RADICAL PROSTATECTOMY:
TUMOR PROCUREMENT:
HISTOLOGIC TYPE
ACINAR ADENOCARCINOMA
HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE):
4 + 5 = 9
TERTIARY PATTERN NOT PRESENT 6 12m = 3 V 3 PW
PERCENTAGE OF DIFFERENT GLEASON PATTERNS .
NOT DETERMINED JV; ““0" ”1‘ ‘ ““1 M
TUMOR LOCATION
APEX
MID
BASE
ANTERIOR
RIGHT % ,. ,
LEFT ,LZ'ZID “'0 ‘ 5
POSTERIOR I C , x, \
EEGFrHT (lddwwémw, ML m H6715 N53 8W1“ /3
EXTRA-PROSTATIC EXTENSION <1- - - -, "f“ _ - T‘ c /- , 5‘
ABSENT i) (1th ‘. WL'LQZKXZL H L) (“k I 7
SEMINAL VESICAL INVASION , -
PRESENT I}; :: 4/0152” LI
LEFT
SURGICAL MARGINS
FREE OF INVASIVE CARCINOMA
LYMPHOVASCULAR INVASION
ABSENT
PERINEURAL INVASION
ABSENT
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: _35%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODEs‘
RIGHT NODAL STATION
NUMBER OF NODES INDENTIFIED: _9_
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
LEFT NODAL STATION
NUMBER OF NODES INDENTIFIED: _6__
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
ADDITIONAL PATHOLOGIC FINDINGS
HIGH-GRADE PROSTATIC INTRA-EPITHELlAL NEOPLASIA
NODULAR HYPERPLASIA
PATHOLOGICAL STAGING
pT3b
pNO
pMX

 

T She
HIPM

Case is

 

Reviewer IniIials

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

instructions; The TC GA Patlwlogic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

 

 

 

 

 

 

 

 

 

 

11525119 Source Site (TSS): . H _‘FSS identiﬁer]: __ TSS Unique Patient identiﬁer:
Completed By [lntcrvlewerNamev‘n OpeiIClinica): 1 _Completed Date:
Diagnosis information '
ll Data Element Entry Alternatives Workingﬂstructions ‘l
P ti l Provide the diagnosis] histologic subtype(s)documemcd on
a 10 ogic Diagnosis . . j 9 3‘ in ~ ~ the initial pathology report for this case. lithe histology for
1 Provided an Initial WHOM; this case is mixed, provide all listed subtypes.
Pathology Report éLc‘AJ‘C‘AJ 1W5}: 7
. i ‘ . Provide the histologic features selected on the TCGA Case
i-lIstOlogiL features of , , . .
2 the sample provided ”0,115,410 AAZEWOGMC/WOH/J Quality Control Form complcicd for tins case.
for TCGA, as reﬂected ‘ . , ‘9 o 3,;
on the CQCF. 6'“);th ”‘3 é
[Discrepancy between Pathology Report and Case Quality Control Form
3 Provide the reason for y ._ A .. k “ Provide II reason describing why the diagnosis on the initial
the discrepancy 77/{5 C4J'1: [3‘ lkjﬁfﬁfcjutbdg. pathology report forthis case is not consistent with the
between the pathology \ diagnosis selected on the TCGA Case Quality Control Form.
1 a 'f i " \
report and the TCGA OUT 0/5 ‘9 l5 Wﬂc “‘5 M015:
Case Quality Control 72/ Z 22‘ age-1'1:— £733 0‘15wa .346“
Form. ' ' ’ ’
my) me maze «Inc we. ﬁw’f
72> rear 2? 5%; new, on; 17H?
’34”: My. we we «Liar/cm“
7mm cmizaidi/‘r (974% i
Name of 1‘35 Reviewing i’rovidc the name of the pathologist who reviewed this case
4 Pathologist or _N ior TEGA.
Bioregositniy Director

 

 

 

 

 

 

I acknowledge that the above informatlon provided by my institution ls true and correct and has been quality controlled.

 

TSS Reviewing Pathologist or Biorepository Director

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chulrman has been informed or is aware of the above discrepancy in dlaynuses.

Principal investigator Signature

I

